TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully Than That to Infliximab/Adalimumab in Spondyloarthritis

Scientific Reports - United Kingdom
doi 10.1038/srep32202
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search